Related Experiment Video
Updated: May 9, 2026
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
[Therapeutic efficacy of compound Xuanju capsule on type III prostatitis]
Guang-Ping Peng1, De-Zhu Qi, Ke-Qing Hu
1Department of Urology, Qingdao Jiaozhou Central Hospital, Jiaozhou, Shandong 266300, China. penggping@163.com
Objective:
To evaluate the therapeutic effect of Compound Xuanju Capsule on type III prostatitis.
Methods:
A total of 242 patients with type III prostatitis diagnosed by the NIH criteria were randomly divided into an experimental and a control group of equal number, the former treated with Compound Xuanju Capsule + Tamsulosin Hydrochloride, and the latter with Quinolinone antibiotics + Tamsulosin and Hydrochloride, both for 6 months. After treatment, we assessed the therapeutic effects based on the NIH-CPSI scores and the improvement of relevant complications.
Results:
All the 242 patients completed the treatment. The total effectiveness rate was 77.69% (94/121) in the experimental group, 71.56% (78/109) in those with complications. In comparison, it was only 47.10% (57/121) in the control group, 31.78% (34/107) in those with complications. Both the NIH-CPSI scores and the improvement of complications were significantly higher in the experimental than in the control group (P < 0.05).
Conclusion:
Compound Xuanju Capsule has a good therapeutic effect on type III prostatitis.
